Recent Updates
Recently added Catalysts
MXCT Positive Sentiment Score: 70/100

MaxCyte to Report First Quarter 2023 Financial Results on May 10, 2023

Wednesday, April 12, 2023 1 min read
Key Takeaway: MaxCyte, Inc. has announced its plans to report the financial results for the first quarter of 2023 on May 10, 2023. The results will be released after the U.S. market closes, followed by a conference call with company management to discuss the outcomes at 4:30 p.m. Eastern Time. Investors are encouraged to register for the call in advance and can access a live and archived webcast on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • MaxCyte is moving forward with its financial disclosures, indicating transparency.
  • The scheduled conference call shows engagement with investors.
  • The focus on cell-based therapeutics suggests ongoing innovation in the company.

Full Press Release Details

ROCKVILLE, Md., April 12, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative cell-based research, today announced that it will release financial results for the first quarter 2023 after the U.S. market close on Wednesday, May 10th, 2023. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.
Earnings Conference Call Details
Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Events” section of the MaxCyte website at https://investors.maxcyte.com/.
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley
Consilium Strategic Communications
Mary-Jane Elliott / Chris Welsh
maxcyte@consilium-comms.com

Frequently Asked Questions

When will MaxCyte release its Q1 2023 financial results?

MaxCyte will release its Q1 2023 financial results on May 10th, 2023.

What time is the earnings conference call scheduled?

The earnings conference call is scheduled for 4:30 p.m. Eastern Time.

How can investors listen to the conference call?

Investors can listen by registering online, ideally a day in advance.

Where can I find the conference call webcast?

The live and archived webcast will be available in the 'Events' section of MaxCyte's website.

Who are the contacts for MaxCyte's corporate communications?

Contacts include Emma Earl, Freddy Crossley, Mary-Jane Elliott, and Chris Welsh.

Tags: MXCT Viatris Investor Conferences Healthcare MaxCyte financial results cell therapeutics conference call
Last updated: Apr 12, 2023